Comment by rposborne

It's actually surprisingly accurate. This part in particular " Anytime a product completely novel and innovative enters this space, it is extremely difficult to obtain early adopter. " Bringing a drug to market is a massive undertaking and most Biotech Investors look at novel treatments as way to high of a risk.